Discussion, page-2

First 2 Last

Share
Profile

Follow
andante

339 Posts.

14

10/12/24

20:42

Post #: 76988755
Share
Originally posted by aceryx: ↑

Hi all,
Thought I would create a thread for newcomers here once this stock takes off. Current timeline and key events are listed below

12 APAS machines have been sold to customers since product launch in Mar 2024
9 machines purchased by Astrazeneca - $7.2 million contract
1 machine purchased by Bristol Myers Squibb - contract value undisclosed
1 machine purchased by Novacina - $0.7 million contract
1 machine purchased by Quest Diagnostic Group - leading provider of clinical laboratories

Currently there are no other technology that can automate contact plate and settle plate reading. Leader in its own respect.

Any pharmaceutical customer who have sterile facilities will benefit from this machine.

Worth to note that Astrazeneca have given funding in the past to develop this technology, and the most recent announcement of the second purchase order solidifies the use of this machine. (Why would they have a repeat order if the machine does not work?- ask yourself that).

Thermofisher is their official distributor. With their recent sales they could be cf+ by mid next year.

Addition revenue that the company has hinted at is validation of contact plate automation. Once this is finalised "annual license fees will apply to
the use of this new analysis module increasing the Company’s annual recurring revenue on any of AstraZeneca’s APAS®
instruments". Recurring revenue from use of machine annually is a big bonus with incoming cf.

At $32 million MC, with at least ~$8-10 million in sales since launch in March, this stock looks primed with any notice of new customers. Not trading far off from its 52 week low, seems like its flying under the radar.

Expand

wasnt there a machine sold to another big pharma..possibly Pfizer?
CC5 Price at posting: 1.8¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CYL

Catalyst Metals confirms resource growth potential at Old Highway

HotCopper Highlights Week 20: MinRes share sale panics; Droneshield's ASIC case & Coles

M79

Mammoth Minerals hits shallow gold as it uncovers further Blue Dick potential

NH3

NH3 Clean Energy pioneering ammonia certification development

CBA

Commonwealth shares have recovered back to $160ea. How much higher can they go?

There are more pages in this discussion • 15 more messages in this thread...

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $54.42M

Open	High	Low	Volume
0.0¢	0.0¢	0.0¢	0

Buyers (Bids)

Vol.	Price($)
5000	2.3¢

Sellers (Offers)

Price($)	Vol.
2.5¢	1221436

Last trade - 13.36pm 15/05/2026 (20 minute delay)

CC5 (ASX) Chart

Day chart unavailable

Discussion, page-2

Catalyst Metals confirms resource growth potential at Old Highway

HotCopper Highlights Week 20: MinRes share sale panics; Droneshield's ASIC case & Coles

Mammoth Minerals hits shallow gold as it uncovers further Blue Dick potential

NH3 Clean Energy pioneering ammonia certification development

Commonwealth shares have recovered back to $160ea. How much higher can they go?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Discussion, page-2

Top Stories

Catalyst Metals confirms resource growth potential at Old Highway

HotCopper Highlights Week 20: MinRes share sale panics; Droneshield's ASIC case & Coles

Mammoth Minerals hits shallow gold as it uncovers further Blue Dick potential

NH3 Clean Energy pioneering ammonia certification development

Commonwealth shares have recovered back to $160ea. How much higher can they go?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News